Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)
Identifieur interne : 001603 ( Main/Exploration ); précédent : 001602; suivant : 001604Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)
Auteurs : Maren Eggers [Allemagne] ; Markus Eickmann [Allemagne] ; Juergen Zorn [Allemagne]Source :
- Infectious Diseases and Therapy [ 2193-8229 ] ; 2015.
Abstract
Since the first case of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infection was reported in 2012, the virus has infected more than 1300 individuals in 26 countries, and caused more than 480 deaths. Human-to-human transmission requires close contact, and has typically occurred in the healthcare setting. Improved global awareness, together with improved hygiene practices in healthcare facilities, has been highlighted as key strategies in controlling the spread of MERS-CoV. This study tested the in vitro efficacy of three formulations of povidone iodine (PVP-I: 4% PVP-I skin cleanser, 7.5% PVP-I surgical scrub, and 1% PVP-I gargle/mouthwash) against a reference virus (Modified vaccinia virus Ankara, MVA) and MERS-CoV.
According to EN14476, a standard suspension test was used to assess virucidal activity against MVA and large volume plating was used for MERS-CoV. All products were tested under clean (0.3 g/L bovine serum albumin, BSA) and dirty conditions (3.0 g/L BSA + 3.0 mL/L erythrocytes), with application times of 15, 30, and 60 s for MVA, and 15 s for MERS-CoV. The products were tested undiluted, 1:10 and 1:100 diluted against MVA, and undiluted against MERS-CoV.
A reduction in virus titer of ≥4 log10 (corresponding to an inactivation of ≥99.99%) was regarded as evidence of virucidal activity. This was achieved versus MVA and MERS-CoV, under both clean and dirty conditions, within 15 s of application of each undiluted PVP-I product.
These data indicate that PVP-I-based hand wash products for potentially contaminated skin, and PVP-I gargle/mouthwash for reduction of viral load in the oral cavity and the oropharynx, may help to support hygiene measures to prevent transmission of MERS-CoV.
Mundipharma Research GmbH & Co.
The online version of this article (doi:10.1007/s40121-015-0091-9) contains supplementary material, which is available to authorized users.
Url:
DOI: 10.1007/s40121-015-0091-9
PubMed: 26416214
PubMed Central: 4675768
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000155
- to stream Pmc, to step Curation: 000155
- to stream Pmc, to step Checkpoint: 000D35
- to stream PubMed, to step Corpus: 001453
- to stream PubMed, to step Curation: 001453
- to stream PubMed, to step Checkpoint: 001376
- to stream Ncbi, to step Merge: 001284
- to stream Ncbi, to step Curation: 001284
- to stream Ncbi, to step Checkpoint: 001284
- to stream Main, to step Merge: 001608
- to stream Main, to step Curation: 001603
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)</title><author><name sortKey="Eggers, Maren" sort="Eggers, Maren" uniqKey="Eggers M" first="Maren" last="Eggers">Maren Eggers</name><affiliation wicri:level="3"><nlm:aff id="Aff1">Labor Prof. Gisela Enders MVZ GbR and the Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Labor Prof. Gisela Enders MVZ GbR and the Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Stuttgart</region><settlement type="city">Stuttgart</settlement></placeName></affiliation></author><author><name sortKey="Eickmann, Markus" sort="Eickmann, Markus" uniqKey="Eickmann M" first="Markus" last="Eickmann">Markus Eickmann</name><affiliation wicri:level="1"><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000000419369756</institution-id><institution>Institute for Virology,</institution><institution>Philipps University of Marburg,</institution></institution-wrap>Marburg, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Marburg</wicri:regionArea></affiliation></author><author><name sortKey="Zorn, Juergen" sort="Zorn, Juergen" uniqKey="Zorn J" first="Juergen" last="Zorn">Juergen Zorn</name><affiliation wicri:level="1"><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.476538.b</institution-id><institution-id institution-id-type="ISNI">0000000403909594</institution-id><institution>Mundipharma Research GmbH & Co.KG,</institution></institution-wrap>Limburg, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Limburg</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26416214</idno><idno type="pmc">4675768</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675768</idno><idno type="RBID">PMC:4675768</idno><idno type="doi">10.1007/s40121-015-0091-9</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000155</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000155</idno><idno type="wicri:Area/Pmc/Curation">000155</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000155</idno><idno type="wicri:Area/Pmc/Checkpoint">000D35</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000D35</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:26416214</idno><idno type="wicri:Area/PubMed/Corpus">001453</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001453</idno><idno type="wicri:Area/PubMed/Curation">001453</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001453</idno><idno type="wicri:Area/PubMed/Checkpoint">001376</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001376</idno><idno type="wicri:Area/Ncbi/Merge">001284</idno><idno type="wicri:Area/Ncbi/Curation">001284</idno><idno type="wicri:Area/Ncbi/Checkpoint">001284</idno><idno type="wicri:doubleKey">2193-8229:2015:Eggers M:rapid:and:effective</idno><idno type="wicri:Area/Main/Merge">001608</idno><idno type="wicri:Area/Main/Curation">001603</idno><idno type="wicri:Area/Main/Exploration">001603</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)</title><author><name sortKey="Eggers, Maren" sort="Eggers, Maren" uniqKey="Eggers M" first="Maren" last="Eggers">Maren Eggers</name><affiliation wicri:level="3"><nlm:aff id="Aff1">Labor Prof. Gisela Enders MVZ GbR and the Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Labor Prof. Gisela Enders MVZ GbR and the Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Stuttgart</region><settlement type="city">Stuttgart</settlement></placeName></affiliation></author><author><name sortKey="Eickmann, Markus" sort="Eickmann, Markus" uniqKey="Eickmann M" first="Markus" last="Eickmann">Markus Eickmann</name><affiliation wicri:level="1"><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000000419369756</institution-id><institution>Institute for Virology,</institution><institution>Philipps University of Marburg,</institution></institution-wrap>Marburg, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Marburg</wicri:regionArea></affiliation></author><author><name sortKey="Zorn, Juergen" sort="Zorn, Juergen" uniqKey="Zorn J" first="Juergen" last="Zorn">Juergen Zorn</name><affiliation wicri:level="1"><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.476538.b</institution-id><institution-id institution-id-type="ISNI">0000000403909594</institution-id><institution>Mundipharma Research GmbH & Co.KG,</institution></institution-wrap>Limburg, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Limburg</wicri:regionArea></affiliation></author></analytic><series><title level="j">Infectious Diseases and Therapy</title><idno type="ISSN">2193-8229</idno><idno type="eISSN">2193-6382</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Introduction</title><p id="Par1">Since the first case of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infection was reported in 2012, the virus has infected more than 1300 individuals in 26 countries, and caused more than 480 deaths. Human-to-human transmission requires close contact, and has typically occurred in the healthcare setting. Improved global awareness, together with improved hygiene practices in healthcare facilities, has been highlighted as key strategies in controlling the spread of MERS-CoV. This study tested the in vitro efficacy of three formulations of povidone iodine (PVP-I: 4% PVP-I skin cleanser, 7.5% PVP-I surgical scrub, and 1% PVP-I gargle/mouthwash) against a reference virus (Modified vaccinia virus Ankara, MVA) and MERS-CoV.</p></sec><sec><title>Methods</title><p id="Par2">According to EN14476, a standard suspension test was used to assess virucidal activity against MVA and large volume plating was used for MERS-CoV. All products were tested under clean (0.3 g/L bovine serum albumin, BSA) and dirty conditions (3.0 g/L BSA + 3.0 mL/L erythrocytes), with application times of 15, 30, and 60 s for MVA, and 15 s for MERS-CoV. The products were tested undiluted, 1:10 and 1:100 diluted against MVA, and undiluted against MERS-CoV.</p></sec><sec><title>Results</title><p id="Par3">A reduction in virus titer of ≥4 log<sub>10</sub> (corresponding to an inactivation of ≥99.99%) was regarded as evidence of virucidal activity. This was achieved versus MVA and MERS-CoV, under both clean and dirty conditions, within 15 s of application of each undiluted PVP-I product.</p></sec><sec><title>Conclusion</title><p id="Par4">These data indicate that PVP-I-based hand wash products for potentially contaminated skin, and PVP-I gargle/mouthwash for reduction of viral load in the oral cavity and the oropharynx, may help to support hygiene measures to prevent transmission of MERS-CoV.</p></sec><sec><title>Funding</title><p id="Par5">Mundipharma Research GmbH & Co.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s40121-015-0091-9) contains supplementary material, which is available to authorized users.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Berry, M" uniqKey="Berry M">M Berry</name></author><author><name sortKey="Gamieldien, J" uniqKey="Gamieldien J">J Gamieldien</name></author><author><name sortKey="Fielding, Bc" uniqKey="Fielding B">BC Fielding</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Zaki, Am" uniqKey="Zaki A">AM Zaki</name></author><author><name sortKey="Van Boheemen, S" uniqKey="Van Boheemen S">S van Boheemen</name></author><author><name sortKey="Bestebroer, Tm" uniqKey="Bestebroer T">TM Bestebroer</name></author><author><name sortKey="Osterhaus, Ad" uniqKey="Osterhaus A">AD Osterhaus</name></author><author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Eggers, M" uniqKey="Eggers M">M Eggers</name></author><author><name sortKey="Eickmann, M" uniqKey="Eickmann M">M Eickmann</name></author><author><name sortKey="Kowalski, K" uniqKey="Kowalski K">K Kowalski</name></author><author><name sortKey="Zorn, J" uniqKey="Zorn J">J Zorn</name></author><author><name sortKey="Reimer, K" uniqKey="Reimer K">K Reimer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Al Saeed, My" uniqKey="Al Saeed M">MY Al-Saeed</name></author><author><name sortKey="Babay, N" uniqKey="Babay N">N Babay</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Spearman, C" uniqKey="Spearman C">C Spearman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="K Rber, G" uniqKey="K Rber G">G Kärber</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Sharma, Vs" uniqKey="Sharma V">VS Sharma</name></author><author><name sortKey="Dutta, S" uniqKey="Dutta S">S Dutta</name></author><author><name sortKey="Taneja, N" uniqKey="Taneja N">N Taneja</name></author><author><name sortKey="Narang, A" uniqKey="Narang A">A Narang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Steinmann, J" uniqKey="Steinmann J">J Steinmann</name></author><author><name sortKey="Paulmann, D" uniqKey="Paulmann D">D Paulmann</name></author><author><name sortKey="Becker, B" uniqKey="Becker B">B Becker</name></author><author><name sortKey="Bischoff, B" uniqKey="Bischoff B">B Bischoff</name></author><author><name sortKey="Steinmann, E" uniqKey="Steinmann E">E Steinmann</name></author><author><name sortKey="Steinmann, J" uniqKey="Steinmann J">J Steinmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lages, Sl" uniqKey="Lages S">SL Lages</name></author><author><name sortKey="Ramakrishnan, Ma" uniqKey="Ramakrishnan M">MA Ramakrishnan</name></author><author><name sortKey="Goyal, Sm" uniqKey="Goyal S">SM Goyal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kariwa, H" uniqKey="Kariwa H">H Kariwa</name></author><author><name sortKey="Fujii, N" uniqKey="Fujii N">N Fujii</name></author><author><name sortKey="Takashima, I" uniqKey="Takashima I">I Takashima</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gralton, J" uniqKey="Gralton J">J Gralton</name></author><author><name sortKey="Tovey, Er" uniqKey="Tovey E">ER Tovey</name></author><author><name sortKey="Mclaws, Ml" uniqKey="Mclaws M">ML McLaws</name></author><author><name sortKey="Rawlinson, Wd" uniqKey="Rawlinson W">WD Rawlinson</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Stittelaar, Kj" uniqKey="Stittelaar K">KJ Stittelaar</name></author><author><name sortKey="Kuiken, T" uniqKey="Kuiken T">T Kuiken</name></author><author><name sortKey="De Swart, Rl" uniqKey="De Swart R">RL de Swart</name></author><author><name sortKey="Van Amerongen, G" uniqKey="Van Amerongen G">G van Amerongen</name></author><author><name sortKey="Vos, Hw" uniqKey="Vos H">HW Vos</name></author><author><name sortKey="Niesters, Hg" uniqKey="Niesters H">HG Niesters</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Sparkes, Jd" uniqKey="Sparkes J">JD Sparkes</name></author><author><name sortKey="Fenje, P" uniqKey="Fenje P">P Fenje</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Ruppach, H" uniqKey="Ruppach H">H Ruppach</name></author></analytic></biblStruct></listBibl></div1></back></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Bade-Wurtemberg</li><li>District de Stuttgart</li></region><settlement><li>Stuttgart</li></settlement></list><tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Eggers, Maren" sort="Eggers, Maren" uniqKey="Eggers M" first="Maren" last="Eggers">Maren Eggers</name></region><name sortKey="Eickmann, Markus" sort="Eickmann, Markus" uniqKey="Eickmann M" first="Markus" last="Eickmann">Markus Eickmann</name><name sortKey="Zorn, Juergen" sort="Zorn, Juergen" uniqKey="Zorn J" first="Juergen" last="Zorn">Juergen Zorn</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001603 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001603 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4675768
|texte= Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26416214" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |